Intracerebral transfection of anti-rabies virus antibodies is an effective therapy for rabies

AbstractRabies is a neurological disease with 100% lethality. Some of the rare human patients who survived after multiple drug treatment had severe sequelae. The present study showed that after 48  h of RABV inoculation, mice injected intracerebrally with anti-RABV F (ab’)2 plus Bioporter ® showed 70% survival compared to the control group, suggesting that transfection of anti-RABV antibodies to the brain may prevent or delay the spread of RABV at an early stage of infection. This result may provide important protocol results in intracellular antibody delivery to prevent the fatal o utcome of the disease.

Source: Journal of NeuroVirology - July 27, 2020 Category: Neurology Source Type: research